过去一年中添加的文章，按日期排序
Hematological Toxicity of [177Lu] Lu-PSMA-617 and [225Ac] Ac-PSMA-617 in RM1-PGLS syngeneic mouse model
MM Vilangattil, A Swaidan, J Godinez, M Taddio… - 2024 - Soc Nuclear Med
18 天前 - … , immunotherapy, and androgen deprivation therapy (ADT… 225 Ac]Ac-PSMA-617,
has shown promising outcomes [3]. … Ac]Ac-PSMA-617 overall survival was significantly more …
has shown promising outcomes [3]. … Ac]Ac-PSMA-617 overall survival was significantly more …
Camrelizumab plus apatinib for advanced renal cell carcinoma patients after first-line tyrosine kinase inhibitor treatment failure: A multicenter phase II trial.
L Jiang, X Zheng, W Wei, Y Peng, D Wang, Z Zhang… - 2024 - ascopubs.org
20 天前 - … : Previous studies have demonstrated the benefit of combining immunotherapy
with … The primary endpoint was progression-free survival (PFS) according to the Response …
with … The primary endpoint was progression-free survival (PFS) according to the Response …
Exosome‐related lncRNA score: A value‐based individual treatment strategy for predicting the response to immunotherapy in clear cell renal cell carcinoma
Z Yang, X Zhang, N Zhan, L Lin, J Zhang… - Cancer …, 2024 - Wiley Online Library
21 天前 - … To construct the ERLRs prognostic score for forecasting the overall survival (…
immunotherapy is currently viewed as a breakthrough in ccRCC treatment that has demonstrated …
immunotherapy is currently viewed as a breakthrough in ccRCC treatment that has demonstrated …
Impact of time-of-day administration of immunotherapy on overall survival among patients with metastatic renal cell carcinoma.
AM Arroyave Ramirez Sr, D Motola Sr… - 2024 - ascopubs.org
21 天前 - … immunotherapy was an independent prognostic factor for death. Conclusions: Our
results demonstrated improved OS and ORR in ICI-treated … efficacy of immunotherapy. This is …
results demonstrated improved OS and ORR in ICI-treated … efficacy of immunotherapy. This is …
Serum IgA as a Prognostic Beacon: Anticipating Systemic Therapy Efficacy in Metastatic Clear Cell Renal Cell Carcinoma
HL Cui, J Wu, G Du, YY Guan, HZ Shi, AP Zhou… - Annals of Surgical …, 2024 - Springer
30 天前 - … for both progression-free survival (PFS) and overall survival (OS). … Taken together,
this study demonstrates that dynamic … , IO-TKI immunotherapy-tyrosine kinase inhibitor, PFS …
this study demonstrates that dynamic … , IO-TKI immunotherapy-tyrosine kinase inhibitor, PFS …
[PDF][PDF] Cancer Treatment with Immune Checkpoint Inhibitors in Kidney Recipients: Renal Transplantation and Cancer
MK Elidrissi, MY Ahmedi - Journal of European Internal Medicine …, 2024 - jeimp.com
31 天前 - … of the immune system via immunotherapy. This revolutionary … demonstrated a
significant enhancement in overall … chemotherapy (the median overall survival in patients who …
significant enhancement in overall … chemotherapy (the median overall survival in patients who …
Abstract PO3-15-05: B cell immunology predict response and survival in PD-1/PD-L1 targeting immune checkpoint inhibition of metastatic breast cancer
C Fremd, M Schulze, M Cetin, H Boehm, B Lenoire… - Cancer Research, 2024 - AACR
48 天前 - … era of T cell immunotherapies, aggregation of B cells within … cancer, bladder and
renal cell cancer, there is an unmet … MIBI-TOF demonstrated a continuum of coordinated B cell …
renal cell cancer, there is an unmet … MIBI-TOF demonstrated a continuum of coordinated B cell …
Synchronous Lung and Colon Cancer: Multidisciplinary Challenges
M Jain, S Parkash, P Devi, B Fissiha… - B80-7. DIAGNOSTIC …, 2024 - atsjournals.org
49 天前 - … in treating high MSI colon cancer, where conventional therapies may not be suitable.
Recent advancements in immunotherapy have shown … improve the survival outcomes for …
Recent advancements in immunotherapy have shown … improve the survival outcomes for …
… Sex on the Oncological Outcomes in Response to Immunotherapy and Antibody-drug Conjugates in Patients with Urothelial and Kidney Cancer: A Systematic Review …
59 天前 - … for metastatic renal cell carcinoma (RCC) and transitional … and male sex has
better overall survival for adjuvant and … and in vivo studies have demonstrated that sex-related …
better overall survival for adjuvant and … and in vivo studies have demonstrated that sex-related …
Innovations 2023 en Oncologie médicale
E Seront, C van Marcke, P Bartoszek… - Louvain …, 2024 - dial.uclouvain.be
61 天前 - … Treatment with immune checkpoint inhibitors, such as anti-PD-1 … form of
immunotherapy, is the first molecule to demonstrate a real improvement in overall survival of …
immunotherapy, is the first molecule to demonstrate a real improvement in overall survival of …